Yam L T, Chaudhry A A, Janckila A J
Ann Intern Med. 1977 Oct;87(4):444-6. doi: 10.7326/0003-4819-87-4-444.
Cytotoxic chemotherapy often induces sustained, severe granulocytopenia in patients with leukemic reticuloendotheliosis. Many of the patients so treated subsequently develop serious infections. Poor marrow reserve has been implicated but lacks supporting evidence as the cause of the granulocytopenia. In six patients we studied with leukemic reticuloendotheliosis, bone marrow showed severe granulocytopenia, blood neutrophil response after intravenous hydrocortisone injection was poor, and leukocyte migration to the site of inflammation showed suboptimal neutrophilia and poor or no mononuclear response. Splenic hypersequestration and pooling were probably not important factors in causing neutropenia, since similar results were seen in patients without spleens. These findings suggest that in this disease the marrow granulocyte reserve and leukocyte mobilization are impaired and the neutropenia is due to poor granulocyte production and not to increased migration of leukocytes to tissues. Cytotoxic chemotherapy should be used with caution in patients with this disease.
细胞毒性化疗常常会在白血病性网状内皮组织增生症患者中诱发持续性的严重粒细胞减少。许多接受此类治疗的患者随后会发生严重感染。骨髓储备功能差被认为是粒细胞减少的原因,但缺乏支持证据。在我们研究的6例白血病性网状内皮组织增生症患者中,骨髓显示严重粒细胞减少,静脉注射氢化可的松后血液中性粒细胞反应不佳,白细胞向炎症部位的迁移显示中性粒细胞增多不理想,单核细胞反应不佳或无反应。脾功能亢进导致的扣押和蓄积可能不是导致中性粒细胞减少的重要因素,因为在无脾患者中也观察到了类似结果。这些发现表明,在这种疾病中,骨髓粒细胞储备和白细胞动员受损,中性粒细胞减少是由于粒细胞生成不足,而非白细胞向组织的迁移增加所致。对于患有这种疾病的患者,应谨慎使用细胞毒性化疗。